Nov 1, 2022 | Antithrombotics
2) This 🆓program is accredited for 0.5h CE/#CME for #physicians #physicianassociates #nurses #nurespractitioners #pharmacists and is supported by a grant from AstraZeneca. See statement of accreditation and faculty disclosures at https://t.co/gvXca4G9Xm.— cardio-met...
Oct 15, 2022 | Antithrombotics
1b) #Physicians #Nurses #Pharmacists #physicianassociate #NPs earn 0.5h CE/#CME from @academiccme for following this 🧵 pic.twitter.com/WTdiTjcABR— cardio-met (@cardiomet_CE) October 18, 2022 3) And we start with a case . . . 79♂️ with HTN, Afib on #apixaban,...
Jul 5, 2022 | Antithrombotics
1b) BTW, Dr. Arya is Theme Leader for #VTE at the upcoming #ISTH2022 congress in London that kicks off this weekend. It will be the most important international meeting of the year in the field of #thrombosis and #hemostasis and we are proud to have our faculty among...
Mar 2, 2022 | Antithrombotics
1) Welcome to an #accredited #tweetorial on a unique emerging (in Ph3 now) option for specifically reversing the #antiplatelet effects of #ticagrelor: it's #bentracimab. Expert faculty is antithrombotic agent reversal guru @md_pollack of @UMMCnews, working to...
Feb 9, 2022 | Antithrombotics
2) When we think about “special populations” in #VTE, we think weight, age, and #cancer status. @aakonc already addressed the last of those (earn credit still at https://t.co/UnPRV6n6ZO). Learn the rest here! Hello to @ProfMakris @bhwords @MiddeldorpS...
Jan 26, 2022 | Antithrombotics
1) Welcome to a new #accredited #tweetorial on a🗝️ topic in #cancer care & #vascular medicine: #VTE (#DVT and #PE). Cancer patients are at⬆️risk from their disease, their comorbidities, & often from their treatment. It's a sticky wicket &...